
RonanRx Inc. YC 申请
San Francisco
RonanRx Inc. 在 Summer 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2026
- 行业
- Healthcare
- 地点
- San Francisco
- 团队规模
- 5
- 状态
- Active
- 已发布
- 2026
创始人
Lloyd ArmbrustFounder/CEO
Emily ColmanFounder
RonanRx Inc. 做什么
RonanRX is a full-stack pharmaceutical company, starting with personalized peptides and GLP-1s. In our first 10 weeks, we went from having no pharmacy to being licensed in 33 states. Since launch, we’ve grown 50% week over week. We manufacture the medications ourselves, sell directly to patients, and eliminate the layers of middlemen that make prescription drugs more expensive. What makes this possible is AI. Traditional pharmaceutical companies are built to manufacture one drug for millions of people. RonanRX is purpose-built to personalize treatment for each patient: different biology, different response, different dose. Patients come directly to RonanRX or through doctors using our platform. Every patient completes our medical intake, meets with a licensed doctor through our telehealth platform, and receives a personalized prescription when appropriate. From there, we manufacture the medication ourselves and deliver it directly to the patient. Labs, wearables, medical history, treatment response, and other health data feed back into the platform so doctors can continuously refine treatment over time. Before AI, doing this for every patient at scale was impossible. We didn't invent the demand we are seeing. 80 Million people are on a GLP-1 and millions more are using Peptides. We're building a better way to manufacture, personalize, prescribe, and deliver them. Our founders have built and exited multiple companies, raised more than $100M, built a $50M U.S. medical manufacturing business, and spent years developing peptide therapeutics at companies including Eli Lilly and AbbVie. We’re just getting started with peptides and GLP-1s. Next comes hormone therapy and the rest of personalized medicine.
RonanRx Inc. 的 YC 申请,重建版
Y Combinator 申请
RonanRx Inc.,Summer 2026 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
RonanRx Inc.
Personalized peptides & GLP-1s, direct to patient.
We are building RonanRX, a pharmaceutical company focused on personalized peptides and GLP-1 medications. Patients complete an online medical intake, meet with a licensed doctor through our telehealth platform, and receive a tailored prescription. We manufacture the drugs ourselves and ship directly to the patient, taking care of every step from medical consultation to delivery. We use AI to make it possible to personalize treatments at scale and close the feedback loop between patient data and ongoing care.
We are based in San Francisco, CA and will continue to be based there after YC.
San Francisco is our home and it's where our team, facility, and network are already set up. It's also the best place for health tech and for building a telehealth company quickly.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 RonanRx Inc. 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 RonanRx Inc. 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 RonanRx Inc. 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
RonanRx Inc. 是哪个 YC 批次的?
RonanRx Inc. 是 Y Combinator Summer 2026 批次的成员。
谁创立了 RonanRx Inc.?
RonanRx Inc. 由 Lloyd Armbrust, Emily Colman 创立。
RonanRx Inc. 做什么?
Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1s
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 RonanRx Inc. 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。